Medytox Overview

  • Founded
  • 2000
Founded
  • Status
  • Public
  • Employees
  • 614
Employees
  • Stock Symbol
  • 086900
Stock Symbol
  • Investments
  • 7
  • Share Price
  • $136.64
  • (As of Monday Closing)

Medytox General Information

Description

Medy-Tox Inc. is a Korea-based company engaged in the development, manufacture, and marketing of biopharmaceuticals. The company's main product is type-A botulium toxin biopharmaceuticals which are used as remedies for blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis diseases and infantile cerebral palsy. The group provides its products under the brand names of Neuronox, Siax and others. It distributes its products within Korean and to overseas markets, such as Japan, China, Russia and Europe, among others.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Stock Exchange
KRX
Primary Office
  • 78, Gangni 1-gil, Ochang-eup
  • Cheongwon-gu
  • Cheongju-si, Chungcheongbuk-do 55432-5604
  • South Korea
+82 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Medytox Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$136.64 $138.48 $105.28 - $220.98 $792M 5.8M 94.4K $10.26

Medytox Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 1,254,320 975,824 1,478,507 2,787,133
Revenue 124,126 119,275 176,576 186,919
EBITDA 97,651 (16,689) 38,619 93,494
Net Income 60,747 (25,050) 22,473 63,655
Total Assets 571,884 428,780 363,905 353,226
Total Debt 120,468 135,125 88,434 74,948
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Medytox Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Medytox‘s full profile, request access.

Request a free trial

Medytox Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Medy-Tox Inc. is a Korea-based company engaged in the development, manufacture, and marketing of biopharmaceuticals. The
Pharmaceuticals
Cheongju-si, South Korea
614 As of 2020
00.000
0000 00.000

0000000

xercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repreh
000000000000000
Trevose, PA
000 As of 0000
000000000

00000000

et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut a
000000000000000
Tarrytown, NY
0000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Medytox Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Lannett Company Corporation Trevose, PA 000 000000000
000000000 00000000 Formerly VC-backed Tarrytown, NY 0000 00000 00000000000 00000
0000 0000000000000 Corporate Backed or Acquired Haifa Bay, Israel 0000 0000 00000000000
000000 00000 Corporation Mumbai, India 0000
000000000000 Corporation Staines-Upon-Thames, United Kingdom 0000 00.00 0000000000.
To view Medytox’s complete competitors history, request access »

Medytox Executive Team (2)

Name Title Board Seat Contact Info
Jung Hyun Ho Ph.D Chief Executive Officer
Gi Hyeok Yang Ph.D Managing Director
To view Medytox’s complete executive team members history, request access »

Medytox Board Members (3)

Name Representing Role Since
Gi Hyeok Yang Ph.D Medytox Managing Director 000 0000
You’re viewing 1 of 3 board members. Get the full list »

Medytox Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medytox Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Medytox‘s full profile, request access.

Request a free trial

Medytox Investments & Acquisitions (7)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000000 000 01-Aug-2020 000000000000000000 Biotechnology
000000000 05-Jul-2020 00000 00000 00 0000 Drug Discovery
0000000 00000000 31-Jan-2020 00000 00000 00 00.000 Drug Discovery
0000000 000 (00000 19-Apr-2019 000000000000000000 Distributors/Wholesale
LifeSprout 06-Mar-2018 Seed Round 00.00 Biotechnology
You’re viewing 5 of 7 investments and acquisitions. Get the full list »